Items per page
Sort by

Send to:

Choose Destination

Results: 14

Cited In for PubMed (Select 20026644)


Casein kinase 2 prevents mesenchymal transformation by maintaining Foxc2 in the cytoplasm.

Golden D, Cantley LG.

Oncogene. 2015 Sep 3;34(36):4702-12. doi: 10.1038/onc.2014.395. Epub 2014 Dec 8.


Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes.

Soccio RE, Chen ER, Lazar MA.

Cell Metab. 2014 Oct 7;20(4):573-91. doi: 10.1016/j.cmet.2014.08.005. Epub 2014 Sep 18.


Inhibition of CRM1-dependent nuclear export sensitizes malignant cells to cytotoxic and targeted agents.

Turner JG, Dawson J, Cubitt CL, Baz R, Sullivan DM.

Semin Cancer Biol. 2014 Aug;27:62-73. doi: 10.1016/j.semcancer.2014.03.001. Epub 2014 Mar 12. Review.


The G32E functional variant reduces activity of PPARD by nuclear export and post-translational modification in pigs.

Duan Y, Brenig B, Wu X, Ren J, Huang L.

PLoS One. 2013 Sep 18;8(9):e75925. doi: 10.1371/journal.pone.0075925. eCollection 2013.


Skp2 regulates subcellular localization of PPARγ by MEK signaling pathways in human breast cancer.

Cheng H, Meng J, Wang G, Meng Y, Li Y, Wei D, Fu C, Deng K, Shen A, Wang H, Dai S.

Int J Mol Sci. 2013 Aug 9;14(8):16554-69. doi: 10.3390/ijms140816554.


Redox control of inflammation in macrophages.

Brüne B, Dehne N, Grossmann N, Jung M, Namgaladze D, Schmid T, von Knethen A, Weigert A.

Antioxid Redox Signal. 2013 Aug 20;19(6):595-637. doi: 10.1089/ars.2012.4785. Epub 2013 Mar 6. Review.


Cognitive enhancement with rosiglitazone links the hippocampal PPARγ and ERK MAPK signaling pathways.

Denner LA, Rodriguez-Rivera J, Haidacher SJ, Jahrling JB, Carmical JR, Hernandez CM, Zhao Y, Sadygov RG, Starkey JM, Spratt H, Luxon BA, Wood TG, Dineley KT.

J Neurosci. 2012 Nov 21;32(47):16725-35a. doi: 10.1523/JNEUROSCI.2153-12.2012.


Dental pulp stem cells differentiation reveals new insights in Oct4A dynamics.

Ferro F, Spelat R, D'Aurizio F, Puppato E, Pandolfi M, Beltrami AP, Cesselli D, Falini G, Beltrami CA, Curcio F.

PLoS One. 2012;7(7):e41774. doi: 10.1371/journal.pone.0041774. Epub 2012 Jul 23.


Research resource: identification of novel growth hormone-regulated phosphorylation sites by quantitative phosphoproteomics.

Ray BN, Kweon HK, Argetsinger LS, Fingar DC, Andrews PC, Carter-Su C.

Mol Endocrinol. 2012 Jun;26(6):1056-73. doi: 10.1210/me.2011-1258. Epub 2012 May 8.


Controlling a master switch of adipocyte development and insulin sensitivity: covalent modifications of PPARγ.

Floyd ZE, Stephens JM.

Biochim Biophys Acta. 2012 Jul;1822(7):1090-5. doi: 10.1016/j.bbadis.2012.03.014. Epub 2012 Apr 4. Review.


PPARγ and Oxidative Stress: Con(β) Catenating NRF2 and FOXO.

Polvani S, Tarocchi M, Galli A.

PPAR Res. 2012;2012:641087. doi: 10.1155/2012/641087. Epub 2012 Mar 5.


The Ras inhibitors caveolin-1 and docking protein 1 activate peroxisome proliferator-activated receptor γ through spatial relocalization at helix 7 of its ligand-binding domain.

Burgermeister E, Friedrich T, Hitkova I, Regel I, Einwächter H, Zimmermann W, Röcken C, Perren A, Wright MB, Schmid RM, Seger R, Ebert MP.

Mol Cell Biol. 2011 Aug;31(16):3497-510. doi: 10.1128/MCB.01421-10. Epub 2011 Jun 20.


Design principles of nuclear receptor signaling: how complex networking improves signal transduction.

Kolodkin AN, Bruggeman FJ, Plant N, Moné MJ, Bakker BM, Campbell MJ, van Leeuwen JP, Carlberg C, Snoep JL, Westerhoff HV.

Mol Syst Biol. 2010 Dec 21;6:446. doi: 10.1038/msb.2010.102.


Molecular Mechanisms and Genome-Wide Aspects of PPAR Subtype Specific Transactivation.

Bugge A, Mandrup S.

PPAR Res. 2010;2010. pii: 169506. doi: 10.1155/2010/169506. Epub 2010 Aug 31.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk